Human breast cancer cell lines, MDA-MB-231 and the MCF-10 series (M1, M2, and M4) were treated with or without the 100-nM MMP2/9 Inhibitor II for 24 h prior to transplantation into the zebrafish embryo. This evidence concerns the gene MMP2 and breast cancer.